
Pfizer Ends COVID-19 Trial With 95% Efficacy
Pfizer Ends COVID-19 Trial With 95% Efficacy
Pfizer Says COVID-19 Vaccine 'Over 90% Effective', Markets Surge
GSK Buys 10% Of CureVac In Vaccine Tech Deal
GSK And Pfizer Complete Consumer Healthcare Joint Venture
GSK To Split Into Two Businesses After Striking Pfizer Consumer Health Deal